Liquid Biopsy

Liquid Biopsy

New Challenges in the era of Immunotherapy and Precision Oncology

1st Edition - October 1, 2022

Write a review

  • Editors: Antonio Russo, Ettore Capoluongo, Antonio Galvano, Antonio Giordano
  • Paperback ISBN: 9780128227039

Purchase options

Purchase options
Available for Pre-Order
Sales tax will be calculated at check-out

Institutional Subscription

Free Global Shipping
No minimum order


Liquid Biopsy: New Challenges in the era of Immunotherapy and Precision Oncology aims to describe links between cancer, precision oncology, and liquid biopsy, focusing on their participation to immunotherapy management. The book provides updated information on the main applications of liquid biopsy and immunotherapy as well as interesting aspects useful for planning basic and translational research activities. It helps readers understand the central aspects of precision medicine in oncology, including the use of new generation technologies for translational and diagnostic settings and the main clinical trials in this area that may be useful during their research.The book is a valuable source for cancer researchers, oncologists and other members of the medical and biomedical field who are interested in learning more about recent developments in liquid biopsy and its relationship with precision medicine and immunotherapy.

Key Features

  • Presents a “highlights section” in every chapter to help readers summarize the main aspects discussed
  • Encompasses case reports to guide the reader on applying what they read in their clinical practice
  • Includes several tables and figures specially created for the book to illustrate the meaning of what is expressed in the text


Cancer researchers, medical scientists, clinicians, graduate students

Table of Contents

  • 1. Foreword
    2. What is precision medicine in oncology?
    3. Immunology and cancer
    4. Liquid biopsy: a right tool in a right context?
    5. How does immunotherapy raise the bar in oncology?
    6. Liquid biopsy and immunotherapy: Is all that glitters gold?
    7. Future perspectives
    8. Glossary
    9. References

Product details

  • No. of pages: 250
  • Language: English
  • Copyright: © Academic Press 2022
  • Published: October 1, 2022
  • Imprint: Academic Press
  • Paperback ISBN: 9780128227039

About the Editors

Antonio Russo

Antonio Russo, MD: the central theme of Dr. Russo’s studies is translational research, meaning the application of molecular genetics in cancer management. He is Principal Investigator in several national and international clinical trials and author of more than 300 peer-reviewed publications listed on Medline-PubMed. Dr. Russo focused his studies on liquid biopsy and its application into the oncology field since 2003. In the following years, he carried out numerous projects and made several collaborations with authoritative colleagues specialized in this field which end in the publication of the first text entirely dedicated to the use of liquid biopsy in the oncology field entitled: Liquid Biopsy in Cancer Patients.

Affiliations and Expertise

Medical Oncology Director, Department of Oncology - A.O.U.P. "P. Giaccone" University Hospital, Italy

Ettore Capoluongo

Ettore Capoluongo, PhD, is molecular geneticist whose job interests are mainly focused on cancer diagnostics and biomarkers identification. He is the Coordinator of two groups of the Italian Society of Clinical Biochemistry and Molecular Biology (SiBioC) and he has been appointed as Member of the Committee on Clinical Molecular Biology Curriculum (C-CMBC) of the IFCC. He has published over 215 publications in peer-reviewed journals.

Affiliations and Expertise

Department of Molecular Medicine and Medical Biotechnologies, Universita Federico II - CEINGE, Biotecnologie Avanzate, Italy

Antonio Galvano

Antonio Galvano, PhD, is Professor of Surgery, Oncology and Stomatology at Università degli Studi di Palermo | UNIPA. He has focused his research efforts on liquid biopsies for cancer diagnosis.

Affiliations and Expertise

Professor of Surgery, Oncology and Stomatology, Universita degli Studi di Palermo | UNIPA · Department of Surgery, Oncology and StomaLiquid Biopsy: tology, Italy

Antonio Giordano

Antonio Giordano, MD, PhD, is an Italian-American pathologist and geneticist, best known for his discovery of Rb2/p130, a tumor suppressor gene. Dr. Giordano is the president, founder and chairman of the board of the Sbarro Health Research Organization (SHRO), a nonprofit organization committed to funding excellence in basic genetic research to cure and diagnose cancer, cardiovascular diseases, diabetes and other chronic illnesses, and to foster the training of young doctors in a spirit of professionalism and humanism.

Affiliations and Expertise

Director of Sbarro Institute for Cancer Research and Molecular Medicine, and  Center of Biotechnology   College of Science and Technology, Temple University, USA

Ratings and Reviews

Write a review

There are currently no reviews for "Liquid Biopsy"